UnitedHealth Group Incorporated (UNH) Holdings Lessened by Ameriprise Financial Inc.
Ameriprise Financial Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,229,504 shares of the healthcare conglomerate’s stock after selling 103,257 shares during the period. Ameriprise Financial Inc. owned about 0.33% of UnitedHealth Group worth $599,207,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group during the second quarter valued at approximately $110,000. Kings Point Capital Management boosted its position in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. BDO Wealth Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $121,000. Finally, Founders Capital Management purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $135,000. Institutional investors and hedge funds own 85.71% of the company’s stock.
UnitedHealth Group Incorporated (NYSE UNH) opened at $210.25 on Tuesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group Incorporated has a 12-month low of $148.56 and a 12-month high of $213.93. The stock has a market capitalization of $202,880.00, a price-to-earnings ratio of 21.86, a P/E/G ratio of 1.56 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the prior year, the firm earned $2.17 EPS. The firm’s revenue was up 8.7% on a year-over-year basis. research analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s payout ratio is 34.09%.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the sale, the director now directly owns 60,834 shares in the company, valued at $12,135,774.66. The disclosure for this sale can be found here. Over the last three months, insiders sold 57,606 shares of company stock worth $11,433,133. 0.89% of the stock is owned by insiders.
A number of brokerages recently issued reports on UNH. Credit Suisse Group began coverage on UnitedHealth Group in a report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price target for the company. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, October 24th. Argus boosted their price target on UnitedHealth Group from $215.00 to $230.00 and gave the company a “buy” rating in a report on Thursday, October 19th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and issued a $219.00 price target (up previously from $210.00) on shares of UnitedHealth Group in a report on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $216.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.